PLASMAKALLIKREINBINDENDE PROTEINE

Patent europeic · EP2521568 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2521568
Numer da la dumonda
EP11732145
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
06-01-2011
Publitgà
14-11-2012
Concedì
25-07-2018
La protecziun finescha il pli tard
05-01-2031
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 39/395 (2006.01)
C07K 16/18 (2006.01)
C07K 16/40 (2006.01)
Prioritad
US 292614 P 06.01.2010
Dumonda PCT
PCT/US2011/020377 06.01.2011
Publicaziun PCT
WO2011/085103 14.07.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Lanadelumab

C02521568/01 · Medicament · Prolungà per diever pediatric · Protecziun dals 06-01-2031 fin ils 05-12-2034

Admissiun 66912 (Swissmedic, 06-06-2019) · Admissiun 68178 (Swissmedic, 05-11-2020) · Admissiun 68178 (Swissmedic, 11-04-2024) · Admissiun 66912 (Swissmedic, 06-04-2018) · Admissiun 68178 (Swissmedic, 30-03-2020) · Admissiun 68178 (Swissmedic, 25-01-2023)

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 21-12-2023

    Adressa midada

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 21.12.2023

  5. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  6. 15-07-2021

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 15.07.2021

  7. 29-05-2021

    Transferì

    Owner
    Dyax Corp., 300 Shire Way, Lexington, MA 02421, USA → Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan

    Published in Swissreg on 29.05.2021

  8. 25-07-2018

    Concedì

    Published in Swissreg on 25.07.2018

Partidas

Possessur

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

SEXTON, Daniel, J.

Melrose, MA 02176, US

VISWANATHAN, Malini

Acton, MA 01720, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.